drugset / Trial / NCT01857232
Dose-finding Study of APD403 to Prevent Nausea and Vomiting After Chemotherapy
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Comparison of efficacy of APD403 at preventing delayed sickness in patients who have received cancer chemotherapy
Timeline
- Start
- 2013-10
- Primary completion
- 2015-02
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amisulpride | Small molecule | 10 mg | Intravenous |
| Subject | Amisulpride | Small molecule | 20 mg | Intravenous |
| Subject | Amisulpride | Small molecule | 40 mg | Intravenous |
| Background | Dexamethasone | Small molecule | — | — |
| Background | Fosaprepitant | Other / unclassified | — | — |
| Background | Ondansetron | Other / unclassified | 8 mg | Intravenous |
| Background | Ondansetron | Other / unclassified | 16 mg | Intravenous |
Indications
No indication recorded.